The calcineurin pathway is an important signal transduction cascade required for T-cell activation and the target for the immunosuppressants cyclosporine A and FK506 (9, 19) . Calcineurin is a highly conserved Ca 2ϩ -calmodulin-activated protein phosphatase composed of a catalytic A subunit and a regulatory B subunit. Calcineurin is also a critical mediator of calcium signaling and numerous cell stress responses in eukaryotic organisms. Calcineurin regulation has been implicated in neuronal elongation (11) , ion channel regulation (2) , heart failure (32), Alzheimer's disease (18) , and a myriad of other human conditions and cellular processes. Patients have been successfully treated with calcineurin inhibitors for a wide spectrum of diseases, most importantly to prevent and treat graftversus-host disease (37) , but also for other indications such as severe asthma (1) , segmental glomerulosclerosis (28) , refractory rheumatoid arthritis (38) , atopic dermatitis, and others.
Fungi are an increasingly important cause of death among both immunocompetent (16) and immunocompromised (15) patients, and yet effective treatments are often lacking. Calcineurin is linked to several infectious agents, including human opportunistic pathogenic fungi such as Cryptococcus neoformans and Candida albicans (5, 24) . Although calcineurin is highly conserved across higher and lower eukaryotes and even the fungal kingdom, it is utilized differently among the major pathogenic fungi. For instance, Cryptococcus neoformans mutants lacking calcineurin were severely growth impaired at 37°C (24) , exhibited defects in hyphal elongation (10) , and were avirulent (13) . With Candida albicans, calcineurin was not required for in vitro survival at 37°C (5) but rather for survival in serum and virulence (3, 5, 33) . It is clear based on these findings that one cannot always extrapolate from one fungal pathogen to another the function of a specific gene or network of genes, as unique ecological niches of individual fungi may result in novel functions for orthologous genes.
Invasive aspergillosis (IA) caused by the opportunistic pathogenic fungus Aspergillus fumigatus is a leading cause of infectious mortality in immunocompromised patients (21) . While the mortality from invasive candidiasis caused by Candida albicans has decreased by 50% over the last two decades, the mortality associated with IA has increased 357% over the same period of time (22) . Unfortunately, the optimal treatment for IA remains elusive. No study has examined the specific role of calcineurin in the pathogenicity of this increasingly important fungal pathogen. Here we show that gene replacement of the calcineurin A (cnaA) locus with an auxotrophic selectable marker led to severe defects in the growth and development of the fungus. These defects substantially affected the ability of A. fumigatus to cause invasive disease, as multiple animal models of IA revealed the ⌬cnaA mutant to be avirulent. Since calcineurin inhibition is successfully employed to treat human immune disorders, it may be possible to manipulate this pathway to develop novel treatment strategies for fungal infections such as the frequently fatal IA.
MATERIALS AND METHODS
Strains, media, and growth conditions. Aspergillus fumigatus strain AF293.1 was used to create the calcineurin A replacement (⌬cnaA) strain (⌬cnaA::A. parasiticus pyrG). AF293.1 is a uracil/uridine-auxotrophic (pyrG Ϫ ) mutant of A. fumigatus strain AF293 (25) . AF293 was used as the wild-type strain for all animal model experiments. Preliminary animal model experiments showed no difference in virulence between AF293 and the pyrG-complemented AF293.1 strain. All A. fumigatus cultures were grown on glucose minimal media as previously described (34) at 37°C unless otherwise specified. An Escherichia coli One-Shot TOP10 strain (Invitrogen, Carlsbad, CA) was used for routine cloning and grown in Luria broth (Fisher Chemicals, Fair Lawn, NJ) supplemented with appropriate antibiotics at 37°C.
Creation of ⌬cnaA mutant and ⌬cnaA ؉ cnaA complement in A. fumigatus. The 1.9-kb A. fumigatus cnaA gene (Afu5g09360; www.cadre.man.ac.uk) was replaced with the 3.1-kb A. parasiticus pyrG gene to create the ⌬cnaA mutant (Fig. 1A) . Approximately 1.1 kb of flanking sequence upstream and downstream of cnaA was cloned to flank the 3.1-kb A. parasiticus pyrG gene in plasmid pJW24 (a gift from Nancy Keller, University of Wisconsin-Madison) to create the replacement construct. A. parasiticus pyrG was used to complement the uracil auxotrophy of AF293.1. This resulting replacement construct plasmid was used as a template to create the ϳ5.3-kb PCR amplicon for use in transformation. AF293.1 (pyrG Ϫ ) was used as the recipient strain, and transformants were selected for growth in the absence of uracil/uridine supplementation. All primers used in this study are listed in Table 1 .
Creation of fungal protoplasts and polyethylene glycol-mediated transformation of A. fumigatus were performed as previously described (7) . Transformants were initially screened by PCR with primers designed to amplify the 1.9-kb cnaA gene, which should be absent in ⌬cnaA strains. Transformants were additionally screened by PCR for the junctions of the cnaA::pyrG allele to indicate replacement and homologous recombination. Specifically, one flanking primer annealed to the cnaA locus outside the disruption construct and the second primer annealed within the pyrG sequence to create an amplicon in transformants that had undergone a homologous recombination event at the cnaA locus. Confirmation was performed via Southern analysis using a digoxigenin labeling system (Roche Molecular Biochemicals, Mannheim, Germany) and a 1.1-kb probe of the 5Ј cnaA flanking sequence as well as a probe for the A. parasiticus pyrG gene.
The ⌬cnaA mutant was complemented by transformation with the wild-type cnaA gene and 1 kb of flanking upstream and downstream sequence. An ϳ4.0-kb complementation construct PCR product was then transformed as detailed above into the recipient ⌬cnaA mutant. No selectable markers were used, and transformants were selected by phenotypic restoration of filamentation. PCR and Southern analyses were performed as described above to confirm that isolates contained both the original cnaA::pyrG deletion allele and a single ectopic copy of the wild-type cnaA gene (⌬cnaA ϩ cnaA strain).
Radial growth, mycelial mass, and conidiation. Radial growth on solid media was obtained by measuring colony diameters of the wild-type, ⌬cnaA mutant, and ⌬cnaA ϩ cnaA strains once every 24 h over a period of 96 h. The inoculum was 10 to 1,000 conidia (1 l of 1 ϫ 10 4 to 1 ϫ 10 6 conidia/ml) inoculated on glucose minimal medium agar and grown at 37°C. Each inoculum of each strain was done in triplicate, and the mean and standard error of colony diameter at each 24-h period are reported. Growth analysis in liquid culture was performed in triplicate using an inoculum of 1 ϫ 10 6 conidia/ml in glucose minimal medium broth and incubated with shaking at 37°C. Growth was analyzed at 24, 48, 72, and 144 h and 14 days of growth. Mycelial mass in liquid culture was quantified in triplicate using 1 ϫ 10 6 conidia/ml in glucose minimal medium broth incubated at 37°C for the stated durations, lyophilized overnight, and weighed.
Conidiation was quantified by harvesting conidia from the wild-type, ⌬cnaA mutant, and ⌬cnaA ϩ cnaA strains. Strains were inoculated as 10 l of 1 ϫ 10 6 conidia/ml onto glucose minimal medium agar and incubated for 96 h. Incubation occurred at four different temperatures (25°C, 30°C, 37°C, and 40°C) to assay any effect on temperature and conidiation. Conidia were harvested with 10 ml of sterile 0.05% Tween 80, filtered through miracloth (EMD Biosciences, La Jolla, CA), and quantified with a hemacytometer. Harvests from each strain at each temperature were performed in triplicate, and the mean and standard error of the total number of conidia per ml collected from each strain at each temperature are reported.
Light and scanning electron microscopy. All light microscopy was performed with a Zeiss microscope using Nomarski optics (differential interference contrast). The wild-type, ⌬cnaA mutant, and ⌬cnaA ϩ cnaA strains were grown at 1 ϫ 10 6 conidia/ml in glucose minimal medium broth and fixed after sampling in 10% neutral buffered formalin. All scanning electron microscopy images were obtained by using an environmental scanning electron microscope (Philips XL30 ESEM TMP; FEI Company, Hillsboro, OR). For hyphal examination, starting cultures of 1 ϫ 10 6 conidia/ml were grown in glucose minimal medium broth for 18 h at 37°C, washed twice in sterile water, and then air dried before viewing. For conidium examination, starting cultures of 20 l of 1 ϫ 10 6 conidia/ml were grown on glucose minimal medium agar plates for 48 h at 37°C and the conidia were harvested from a fresh plate with double-sided tape. Conidia were treated with a sputter coater (Hummer 6.2; Anatech, Springfield, VA) prior to examination.
Murine inhalational model of invasive aspergillosis. Six-week-old CD1 male mice (Charles River Laboratories) (mean weight, 22.5 g) were immunosuppressed with both cyclophosphamide (Cytoxan; Bristol-Myers Squibb, Princeton, NJ) at 150 mg/kg of body weight administered intraperitoneally (i.p.) on days Ϫ2 and ϩ3 of infection and triamcinolone acetonide (Kenalog-40; Bristol-Myers Squibb, Princeton, NJ) at 40 mg/kg administered subcutaneously (s.c.) on days Ϫ1 and ϩ6 of infection. Mice were housed under sterile conditions and supplied sterile drinking water supplemented with vancomycin (1 mg/ml), gentamicin (0.2 mg/ml), and clindamycin (1 mg/ml). Four groups of 20 immunosuppressed, unanesthetized mice each inhaled 40 ml of an aerosolized suspension of 1 ϫ 10 9 conidia/ml of the wild-type, ⌬cnaA mutant, or ⌬cnaA ϩ cnaA strain or diluent control (0.05% Tween 80) in a Hinners inhalational chamber for 30 min as previously described (35) . Mice were evaluated for morbidity and mortality in a blinded fashion twice daily. Survival was plotted on a Kaplan-Meier curve for each Aspergillus strain, and a log rank test was used for pairwise comparison of survival. Statistical significance was defined as a two-tailed P value of Ͻ0.05.
Other distinct animal models of invasive aspergillosis. Studies with a separate murine inhalational model conducted at a second laboratory used outbred ICR mice (Harlan Sprague Dawley, Indianapolis, IN) (weight range, 19 to 21 g) immunosuppressed with cyclophosphamide at 250 mg/kg administered i.p. and cortisone acetate at 250 mg/kg administered s.c. 2 days prior to infection and then again on the third day after infection with cyclophosphamide at 200 mg/kg administered i.p. and cortisone acetate at 250 mg/kg administered s.c. Mice were administered ceftazidime at 50 mg/kg s.c. daily to prevent bacterial infection. Four groups of 20 immunosuppressed mice inhaled an aerosolized suspension of 1 ϫ 10 9 conidia/ml of the wild-type, ⌬cnaA mutant, or ⌬cnaA ϩ cnaA strain or diluent control for 1 h in an acrylic aerosol chamber. Mice were evaluated in a fashion similar to that for the other inhalational model system.
The wild-type, ⌬cnaA mutant, and ⌬cnaA ϩ cnaA strains or diluent control were all used in additional separate animal models of invasive aspergillosis. In a murine intranasal model, 8-week-old DBA/2 male mice (Jackson Laboratories, Bar Harbor, ME) (mean weight, 22 g) were immunosuppressed with a single dose of triamcinolone acetonide at 40 mg/kg 1 day prior to infection. Four groups of 10 immunosuppressed mice were intranasally infected with 3 ϫ 10 4 conidia (30 l of 1 ϫ 10 6 conidia/ml). In a murine intravenous model, 6-week-old CD1 male mice (mean weight, 22 g) were not immunosuppressed and four groups of 10 mice were intravenously infected through the lateral tail vein with 8 ϫ 10 6 conidia (200 l of 4 ϫ 10 7 conidia/ml) as previously described (8) . In an invertebrate model, sixth-instar larvae of the greater wax moth, Galleria mellonella (Vanderhorst Inc., Saint Marys, OH) (17, 31) , were infected into the hemocoel with 1 ϫ 10 6 conidia (5 l of 2 ϫ 10 8 conidia/ml) as previously described (23) . Four groups of 15 larvae were infected. Survival was plotted on a Kaplan-Meier curve for all animal models, and a log rank test was used for pairwise comparison of survival. Statistical significance was defined as a two-tailed P value of Ͻ0.05. The IACUC committees of both Duke University and the University of Texas Health Science Center at San Antonio approved all respective murine protocols.
Histopathologic and CFU quantification of fungal burden. To evaluate in vivo histopathologic progression of disease, four groups of nine additional mice were similarly infected in the first murine inhalational model with each strain and euthanized at defined time points (days ϩ3, ϩ5, and ϩ7 after infection). Lungs were harvested and stained with hematoxylin and eosin to characterize inflam-mation and Gomori's methenamine silver stain to document fungal invasion. A veterinary murine pathologist evaluated each lung section in a blinded fashion to quantify infection according to a five-point pulmonary infarct score that incorporated necrosis, hemorrhage, edema, and hyphal presence as previously described (35) .
In order to quantify fungal burden of disease, four groups of 30 additional mice were similarly infected in the second laboratory's murine inhalational model and euthanized at defined time points (days ϩ3, ϩ5, and ϩ7 after infection) for determination of CFU in the lungs. Additionally, five mice infected with each strain were evaluated for CFU in the lung at 1 h after infection to document uniform exposure with each strain. The Kruskal-Wallis test with Dunn's posttest was used for analysis of fungal burden.
RESULTS

A. fumigatus strain creation.
To study the role of calcineurin in A. fumigatus tissue invasion and pathogenicity, we successfully constructed a calcineurin A-deficient mutant by replacing the A. fumigatus cnaA gene with the A. parasiticus pyrG gene (Fig. 1A) . Transformation of the uracil/uridine-auxotrophic A. fumigatus strain AF293.1 with the cnaA replacement construct yielded 28 transformants, including 9 with a profound lack of filamentation and growth on glucose minimal medium agar. Eight transformants were further analyzed, four with filamentation defects and four with no obvious filamentation defect. The four transformants with filamentation defects had both PCR amplicons with primers designed to amplify the predicted cnaA replacement locus after homologous recombination and no detectable PCR amplicon with primers designed to amplify the wild-type cnaA locus. The four transformants without any obvious filamentation defects each lacked PCR amplicons for the replacement locus and had amplicons for the wild-type locus.
To confirm cnaA replacement, Southern analysis with BamHI-digested genomic DNA was performed (Fig. 1B) . Wild-type strain AF293 yielded predicted bands of 3.3 kb and 9.4 kb, while in the four transformants (CNAKO-7, -16, -18, and -19) with filamentation defects there were bands of 3.3 kb, 3.8 kb, and 1.4 kb and absence of the 9.4-kb band. This confirmed the predicted replacement of cnaA with pyrG and the 1.4-kb band via a tandem insertion of the replacement construct into the cnaA locus. Two of the mutants had banding patterns that suggested multiple insertions of the replacement construct (CNAKO-16 and -18), so those transformants were not further pursued. The remaining two mutants underwent repeat Southern analysis with HindIII-, KpnI-, ApaI-, and NdeI-digested genomic DNA, and all yielded predicted band sizes consistent with a tandem insertion of the replacement construct into the cnaA locus. Additional Southern analysis using a probe for the 3.1-kb A. parasiticus pyrG gene yielded a single band in both mutants and an absence of a band in the wild type, suggesting a single insertion of the replacement allele into the cnaA locus. One of the two mutants, CNAKO-19, was then chosen and single spore isolated twice. Southern analyses were repeated after single spore isolation to confirm the replacement, and this strain was renamed the ⌬cnaA mutant for continuation throughout the in vitro and animal model experiments. The other mutant, CNAKO-7, underwent in vitro growth and conidiation experiments and yielded results similar to those for CNAKO-19 but was not continued for the extensive animal model experiments.
To complement the cnaA defect in the ⌬cnaA mutant strain, a PCR product containing the entire cnaA wild-type locus plus 1 kb of additional 5Ј and 3Ј sequence was transformed into the recipient ⌬cnaA mutant strain and colonies were selected based on restoration of filamentation. A total of seven transformants with normal filamentation and growth were obtained. PCR screening of three transformants (CNACOMP-2, -4, and -6) with the same primers as for the replacement yielded all three strains with the flanking products, indicating preservation of the cnaA::pyrG replacement locus as well as restoration of cnaA and thus an ectopic insertion of the cnaA complementation construct. Southern analysis with AgeIdigested genomic DNA revealed that all three transformants had ectopic insertions of the cnaA complementation construct, but only one (CNACOMP-4) had a single insertion event (Fig.  1C) . CNACOMP-4 was single spore isolated twice, and Southern analyses were repeated to confirm the complementation. This strain was renamed the ⌬cnaA ϩ cnaA strain for continuation throughout the in vitro and animal model experiments. Confirmation of cnaA gene replacement and complementation was also assessed using real-time reverse transcriptase PCR to amplify a 117-bp section of cnaA. PCR results revealed gene expression of cnaA in both the wild-type and ⌬cnaA ϩ cnaA strains but not the ⌬cnaA mutant. Calcineurin is necessary for filamentous growth. The ⌬cnaA mutant had profound defects in filamentation and growth compared to the wild-type and ⌬cnaA ϩ cnaA strains ( Fig. 2A) . After 21 days of growth on glucose minimal medium agar, ⌬cnaA mutant colonies grew only 3 cm, whereas wild-type and ⌬cnaA ϩ cnaA colonies grew rapidly and completely filled the agar surface with expanding filaments. Quantification of radial growth (Table 2) confirmed the dramatically stunted growth of the ⌬cnaA mutant compared to that of the wild-type and ⌬cnaA ϩ cnaA strains. The ⌬cnaA mutant phenotype was apparent regardless of inoculum concentration; all concentrations (1 ϫ 10 2 to 1 ϫ 10 6 conidia) demonstrated a severely restricted growth pattern with a lack of appreciable lateral filamentation and limited aerial growth. The growth and filamentation defects in the ⌬cnaA mutant compared to the wild- type and ⌬cnaA ϩ cnaA strains were also unaffected by incubation at several temperatures (25°C, 30°C, 37°C, and 40°C). In liquid culture, ⌬cnaA mutant hyphae appeared more compact, more dense, and extremely blunted, while the hyphae of the wild-type and ⌬cnaA ϩ cnaA strains formed long, branching, dispersed filaments (Fig. 2B ) that were indistinguishable from each other. Analyses at 24, 48, 72, and 144 h and later at 14 days of growth all demonstrated no significant advancement in hyphal extension in the ⌬cnaA mutant. Mycelial dry weight of the ⌬cnaA mutant was also decreased compared to that of the wild-type and ⌬cnaA ϩ cnaA strains (Table  3 ). There were no in vitro growth conditions found in which the ⌬cnaA mutant exhibited near-wild-type growth. However, dark-field microscopy revealed the presence of septa in the ⌬cnaA mutant.
Examination by scanning electron microscopy revealed pro-
FIG. 2. Calcineurin is necessary for filamentous growth. (A)
A. fumigatus conidia (1 ϫ 10 3 conidia/ml) were incubated on glucose minimal media at 37°C for 96 h, revealing poor growth and filamentation in the ⌬cnaA mutant. (B) A. fumigatus conidia (1 ϫ 10 6 conidia/ml) grown in glucose minimal medium broth at 37°C were sampled at specified time points (144 h is shown), demonstrating blunted hyphal growth of the ⌬cnaA mutant. Magnification, ϫ40 with Nomarski optics (differential interference contrast). Bar, 5 m. found hyphal loss and blunting in the ⌬cnaA mutant compared to the wild-type and ⌬cnaA ϩ cnaA strains (Fig. 3) . The resulting dense mass of shortened hyphae lacked the extensive lattice of invading hyphae seen with the wild-type and complemented strains. There were no clear hyphal extensions seen, as many of the hyphal arms were absent at the point of branching, creating a distinct "club" appearance. These results all suggest that calcineurin is required for normal filamentous growth in A. fumigatus. Calcineurin is necessary for normal conidiation. In addition to defects in filamentation and growth, the A. fumigatus ⌬cnaA mutant was found to have substantial conidiation defects. To understand the effect of environmental influences on conidiation of the ⌬cnaA mutant, we examined several different conditions. Quantitative conidiation assays demonstrated a significant decrease in conidium production at each of several temperatures (25°C, 30°C, 37°C, and 40°C) in the ⌬cnaA mutant compared to levels for the wild-type and ⌬cnaA ϩ cnaA strains. For example, mean conidia harvested after growth at 37°C for the wild-type, ⌬cnaA mutant, and ⌬cnaA ϩ cnaA strains were 1.12 ϫ 10 8 , 9.15 ϫ 10 6 , and 1.55 ϫ 10 8 conidia per ml, respectively. Conidiation by the ⌬cnaA mutant was also markedly inhibited at extreme pHs, 4.5 and 9.5, compared to that of the other strains but was similar to that of the wild-type and ⌬cnaA ϩ cnaA strains at pH 5.5 to 7.5, suggesting a decreased ability to produce conidia under more stressful environmental conditions. All other experiments utilized glucose minimal media with a standard pH of 6.5 (34) .
Higher magnification with scanning electron microscopy revealed two prominent morphological conidial defects in the ⌬cnaA mutant that were not apparent by observation on solid media. The conidia of wild-type A. fumigatus are coated with hydrophobic proteins called rodlets which extend out from the conidial surface and are thought to be related to conidial adhesive properties (39) . However, the ⌬cnaA mutant conidia appeared to lack these surface rodlets (Fig. 4) and instead to possess smooth conidial surfaces. Also, the ⌬cnaA mutant conidia did not appear as single, dispersed conidia, as did conidia of the wild-type and ⌬cnaA ϩ cnaA strains, but rather only as long chains of conidia that required 0.05% Tween 80 for separation. The ⌬cnaA mutant conidia were connected via disjunctors, generally thought to be cellular junctions between conidia, which linked the normally individual conidia.
Calcineurin is required for pathogenicity in distinct animal models. To test the virulence of the ⌬cnaA mutant, a murine inhalational model of invasive pulmonary aspergillosis was utilized to mimic human disease (35) . Infection with the wild-type strain yielded 90% mortality by 14 days after infection (Fig.  5A ), while infection with the ⌬cnaA mutant led to only 10% mortality (P Ͻ 0.001). The remaining animals infected with the wild-type strain died 17 days after infection, while all animals infected with the ⌬cnaA mutant survived until the experiment was terminated at 28 days. Importantly, animals infected with the ⌬cnaA mutant were symptomatically indistinguishable from uninfected control animals during the entire experimental course. Animals infected with wild-type and ⌬cnaA ϩ cnaA strains displayed progressive and severe signs of invasive disease that have been well described previously, including ruffled fur, hunched posture, and an increased respiratory rate. A likely explanation for the restoration of in vitro growth and conidiation and yet an incomplete restoration of pathogenicity of the ⌬cnaA ϩ cnaA strain in the animal model is the inoculum utilized. Each strain was diluted to approximately 1 ϫ 10 9 conidia/ml prior to infection, but quantification just after inoculum delivery revealed a markedly lower inoculum in the ⌬cnaA ϩ cnaA strain (2.3 ϫ 10 7 conidia/ml) than in the wild type (6.8 ϫ 10 8 conidia/ml) and the ⌬cnaA mutant (1.3 ϫ 10 9 conidia/ml). This corresponds to our preliminary work where a lower infectious inoculum led to decreased mortality (35) . Additional fundamentally distinct animal models, all with purposefully unique attributes encompassing animal species, immunosuppression, inoculum, and delivery, were employed to robustly demonstrate the lack of pathogenicity with the ⌬cnaA mutant. Intranasal, intravenous, and additional inhalational murine models as well as an invertebrate wax moth larva model all demonstrated similar profound attenuations of pathogenicity following infection with the ⌬cnaA mutant compared to results following infection with the wild-type and ⌬cnaA ϩ cnaA strains (Fig. 6) .
Another model of murine inhalational invasive pulmonary aspergillosis was performed in a second laboratory with a different immunosuppressive regimen and a different animal strain. This ensured that results of ⌬cnaA mutant disease would not be laboratory or host specific through changing the technical and host factors. This second inhalational model demonstrated that infection with the wild-type strain yielded 100% mortality by 11 days after infection, while infection with the ⌬cnaA mutant led to only 5% mortality (P Ͻ 0.001). In the murine intranasal model of invasive pulmonary aspergillosis, infection with the wild-type strain yielded 50% mortality by 14 days after infection, while infection with the ⌬cnaA mutant led to 0% mortality (P ϭ 0.011). In the murine intravenous model of invasive systemic aspergillosis, infection with the wild-type strain yielded 50% mortality by 14 days after infection, while infection with the ⌬cnaA mutant again led to 0% mortality (P ϭ 0.012). The invertebrate wax moth model of invasive aspergillosis showed findings similar to those of the murine models. Specifically, infection with the wild-type strain yielded 80% mortality by 5 days after infection, while infection with the ⌬cnaA mutant led to 7% mortality (P Ͻ 0.001). In every animal model, inoculation with the diluent control (0.05% Tween 80) resulted in 0% mortality.
Infection with the ⌬cnaA mutant results in decreased invasion and fungal burden. Histopathologic analysis revealed extensive invasive hyphae throughout lung sections from additional animals infected in the murine inhalational model with both the wild-type and ⌬cnaA ϩ cnaA strains but a complete absence of hyphae in animals infected with the ⌬cnaA mutant at all time points examined (Fig. 5B) . Additionally, there was minimal lung inflammation in animals infected with the ⌬cnaA A. fumigatus conidia (1 ϫ 10 6 conidia/ml) were grown in glucose minimal medium broth for 18 h at 37°C. ⌬cnaA mutant hyphae show profound blunting that leads to a more compact hyphal mass, while the wild-type and ⌬cnaA ϩ cnaA strains show similar normal morphologies. Levels of magnification by environmental scanning electron microscopy are shown. In animals infected with wild-type and ⌬cnaA ϩ cnaA strains, infiltration of the alveoli with phagocytic cells and debris and alveolar destruction were observed. Uninfected control mice showed no architectural changes in the lungs. Pulmonary infarct scores (35) at each time point during infection were greater for the wild-type and ⌬cnaA ϩ cnaA strains than for the ⌬cnaA mutant. The mean pulmonary infarct score at 7 days after infection for the ⌬cnaA mutant was 0, compared to a mean score of 8.5 for the wild-type strain and 9.0 for the ⌬cnaA ϩ cnaA strain. The only pulmonary damage seen with the ⌬cnaA mutant at any time point occurred after 7 days of infection and involved only slight inflammation but no apparent hyphae, necrosis, hemorrhage, or edema in the lung tissue. In the immunosuppressed, uninfected control mice, there were no findings of necrosis, hemorrhage, or edema at any time point.
In the separate evaluation of quantitative fungal burden in the murine inhalational model, infection with the ⌬cnaA mutant demonstrated significantly less lung fungal burden at all three time points examined than did infection with the wildtype or ⌬cnaA ϩ cnaA strain (Table 4) . This third measure again demonstrated the lack of in vivo growth, lung invasion, and disease establishment with the ⌬cnaA mutant. The absence of rodlets and conidial clumping in the ⌬cnaA mutant originally suggested a possible mechanistic barrier to descending into the alveoli to explain the lack of virulence and decreased fungal burden in the inhalational model. However, analysis of animal lungs 1 h after inhalation revealed the clear presence of CFU from the ⌬cnaA mutant, wild-type, and ⌬cnaA ϩ cnaA strains (3.53 Ϯ 0.16, 4.46 Ϯ 0.24, and 4.34 Ϯ 0.21 log 10 CFU/g lung tissue [means Ϯ standard errors], respectively). Although there was significant reduction in the fungal burden reaching the lungs (P ϭ 0.0092), likely due to the ⌬cnaA mutant's conidial defect, this confirmed that the virulence defect was not due simply to a complete lack of inhalation of the ⌬cnaA mutant but also to the mutant's inability to grow and produce disease directly within the tissue.
DISCUSSION
In this study, we report the creation of an A. fumigatus strain deficient in calcineurin A. The cnaA gene in A. fumigatus is not (30) , which is now understood to be distantly related based on recent whole-genome analyses (14) . The A. fumigatus ⌬cnaA mutant displays significant physiological defects that critically affect the fitness of the fungus. While not lethal, replacement of the cnaA gene leads to extremely stunted growth in A. fumigatus, suggesting that calcineurin plays a global regulatory role in morphology, growth, and conidial formation. The drastic in vitro phenotypic defects associated with fungal growth seen with the ⌬cnaA mutant likely led to a significant decrease in its ability to establish disease even in an immunocompromised host. The conidia are the infectious propagules that initiate human disease upon inhalation of this ubiquitous fungus. The ⌬cnaA mutant formed unique long conidial chains, and electron microscopy showed the conidia of the ⌬cnaA mutant linked by disjunctors. Surface rodlets, formed by hydrophobins, appeared to be absent on the ⌬cnaA mutant. A deletion of a gene for rodlet formation (⌬rodA) in A. fumigatus had no effect on virulence (39), so it is unlikely that the absence of rodlets alone contributed to the significant pathogenicity defect seen with the ⌬cnaA mutant. An association between rodA and the calcineurin pathway and molds has not previously been established, and expression of rodA was not examined with the ⌬cnaA mutant. Thus, it is not clear if cnaA directly regulates rodlet formation.
Similarly to all other infectious pathogens, Aspergillus growth plays a crucial role in the establishment of human disease. This is underscored by the fact that the two most effective classes of antifungals for the preferred treatment of invasive aspergillosis both inhibit growth of A. fumigatus as their mechanism of action. The triazole class of antifungals inhibits ergosterol production in the fungal cell membrane, while the echinocandin class inhibits glucan synthesis in the fungal cell wall. In one study there was a direct correlation between in vitro growth and in vivo virulence of A. fumigatus in an animal model (26) , indicating that genes involved in growth of the fungus are likely important pathogenicity determinants as invasive disease is established. For instance, disruption of A. fumigatus rasB, a gene involved in morphogenesis (12) , cgrA, a gene suspected to be involved in ribosome synthesis (4), or rhbA, a gene implicated in nitrogen sensing (27) , showed defects in growth and attenuated disease in an animal model. However, disruption of each of these genes did not yield the same severity of growth interruption or pathogenicity attenuation as the ⌬cnaA mutant. Hyphal growth in A. fumigatus appears to occur through apical extension from a germling, but the molecular mechanisms underlying this extension and their contributions to virulence are unknown. In a concurrent work utilizing a Ku80 mutant background of A. fumigatus (10a), there is brief mention of a growth defect in a mutant lacking calcineurin A (referred to as calA) but no report on virulence. Our results actually suggest that calcineurin controls key steps in hyphal polarized growth and morphology in A. fumigatus hyphae and the critically important ability to invade tissue with this growth. Our ⌬cnaA mutant can form septations but is profoundly limited in its apical extension. Our previous work with pharmacologic calcineurin inhibitors suggested a role for calcineurin in hyphal extension and an impact on the fungal cell wall since our ⌬cnaA mutant phenotype was similar to that of A. fumigatus treated with an echinocandin antifungal which specifically targets the ␤-(1, 3)-D-glucan synthase (36) . Preliminary staining with the cell viability fluorescent dyes 5,(6)-carboxyfluorescein diacetate (CFDA) and bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC), which stain live and dead cells, respectively, also localized the antifungal activity of calcineurin inhibitors to the hyphal tips. Furthermore, the hyphal morphology of the ⌬cnaA mutant is similar to the growth arrest and increase in hyphal branching seen with inducible expression of antisense RNA of calcineurin A in the nonpathogenic model filamentous fungus Neurospora crassa (29) . Similarly, RNA interference silencing of calcineurin B in the model slime mold Dictyostelium discoideum resulted in cells with short stalks and spore heads with additional tips (6), a phenotype likely related to that observed with the A. fumigatus ⌬cnaA mutant. In contrast, calcineurin plays little or no demonstrable role in filamentous growth in the invasive dimorphic fungal pathogen C. albicans (3, 5) , highlighting that the role of this conserved gene differs among opportunistic fungal pathogens.
Few genetic mutants of A. fumigatus created so far have led to defects in survival when tested in animal models. Furthermore, most other A. fumigatus mutants created to date have been tested for pathogenicity defects only in that laboratory's single animal model. With the potential inherent differences in each laboratory's model system and the lack of effective standardizations, it may be difficult to compare interlaboratory results and make definitive statements on the virulence of mutants. Therefore, we purposefully tested our ⌬cnaA mutant in five fundamentally distinct animal models at two independent laboratories to conclusively confirm the profound defect in pathogenicity of the ⌬cnaA mutant. The power of this approach is the specific differences in each animal model all pointing toward the same conclusion of the lack of virulence of the ⌬cnaA mutant.
Multiple animal models of invasive aspergillosis were used to assess questions of both the effect of host immune function on the ⌬cnaA mutant and disease progression, as well as the in vitro conidial and hyphal defects of the ⌬cnaA mutant and in vivo disease establishment. The wide spectrum of animal models used helped answer both important questions. The animals' immune function status included profoundly and persistently immunosuppressed animals with repeated doses of two mechanistically different agents in both inhalational models, transiently immunosuppressed animals with a single dose of a single agent in the intranasal model, a fully immunocompetent animal in the intravenous model, and an immunocompetent invertebrate animal, which possesses a remarkably simpler immune system, in the wax moth model.
The invertebrate wax moth model has been used recently to gauge A. fumigatus virulence (17, 31) , and this unique newer model again revealed a difference in the ⌬cnaA mutant versus the wild-type and ⌬cnaA ϩ cnaA strains. Here the growth of the ⌬cnaA mutant was severely restricted in an environment without high temperatures and without the demands of a sophisticated innate and adaptive immunity as seen in the mammalian models. This crucial difference helps to separate the organism's ability to grow in the host, which proves more difficult in the complex mammalian system with its changing immunity and immunosuppression. Clearly the immunosuppressed mammalian models are useful and clinically relevant, but they are also systems where we and others have demonstrated the importance of the host immune system playing a vital and complex role in the establishment and outcome of infection (35) . In the more complex models, it is increasingly more difficult to separate organism damage from host damage. However, with the addition of this simpler moth model to more completely explore various host immunologic backgrounds, we appreciate the direct impact of severely restricted fungal growth on the pathogenesis and outcome of invasive disease.
The issues of infectious delivery and its role in the lack of pathogenicity of the ⌬cnaA mutant were equally evaluated in the multiple animal models. Since the ⌬cnaA mutant possessed a conidial defect, it was important to validate that this defect alone did not affect pathogenicity. While examination of CFU in the lungs after 1 h of infection in the inhalational models demonstrated that there were significant differences in the conidia reaching the alveoli, it was conceivable that a mutant with a defect which created large chains of conidia might bias an aerosol model which required inhalation of the organism. Therefore, we also utilized an intranasal model (12) with direct instillation in the animal's nares to circumvent any unknown aerosolization issues that a conidial defect might confer.
As a final validation that inoculum delivery methodology was not the sole reason for a profound difference in pathogenicity, an intravenous inoculation was utilized to definitively nullify any conidial defect that might affect delivery of the fungus to the tissue. Here the conidia were directly intravenously injected into the animal. While this model does not, in our opinion, accurately mimic human acquisition of invasive aspergillosis, the system has been utilized successfully in the past to adequately create invasive disease. For our purposes, the direct injection allowed elimination of all experimental variables related to initial delivery of inoculum and still demonstrated the substantial effect of the ⌬cnaA mutant on growth in the host tissue.
Taken together, our results provide evidence that calcineurin is profoundly involved in A. fumigatus growth, infectivity, tissue invasion, and finally pathogenicity. Calcineurin is an excellent therapeutic target that could potentially be used to improve outcomes of IA, as it centers on halting the otherwise robust growth of this fungus. The best predictor of a patient's likelihood of survival from IA is recovery of immune function, as the current antifungal armamentarium largely serves only to delay growth and progression of this deadly fungus until the body mounts an effective immune response. Drastically slowing (20) . Since the ⌬cnaA mutation stunts growth of A. fumigatus in multiple in vitro formats, resulting in a lack of hyphal invasion in the infected lung and a dramatic attenuation of pathogenicity in multiple distinct animal models, this target should also have great potential as an antifungal strategy for newer agents. Improving patient survival with IA remains a challenge, and harnessing the conserved calcineurin pathway offers considerable promise. Our studies reveal that calcineurin plays a conserved role in fungal pathobiology but via unique specialization across the different fungal genera and now even Aspergillus species. The shared role of calcineurin in mediating fungal growth in vitro and in vivo and subsequent inability to establish invasive disease may be exploitable with drug analogs that target this fungal Achilles' heel yet spare host calcineurin function. As demonstrated in other disease processes where this pathway can be modulated to improve outcomes (1, 28, 38) , our data suggest that this may be possible for IA. The exciting prospect lies in modulating in vivo fungal growth to drastically stunt the growth, invasiveness, and ultimately mortality of IA.
